Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 982317, 9 pages
http://dx.doi.org/10.1155/2013/982317
Review Article

Natural Products and Biological Activity of the Pharmacologically Active Cauliflower Mushroom Sparassis crispa

Research & Development Center, Unitika Ltd., 23 Uji-Kozakura, Uji, Kyoto 611-0021, Japan

Received 4 October 2012; Accepted 25 February 2013

Academic Editor: Fabio Ferreira Perazzo

Copyright © 2013 Takashi Kimura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. P. Wasser and A. L. Weiss, “Medicinal properties of substances occurring in higher basidomycetes mushrooms: current perspectives,” International Journal of Medicinal Mushrooms, vol. 1, pp. 31–62, 1999. View at Google Scholar
  2. A. Hasegawa, M. Yamada, M. Dombo, R. Fukushima, N. Matsuura, and A. Sugitachi, “Sparassis crispa as biological response modifier,” Gan To Kagaku Ryoho, vol. 31, no. 11, pp. 1761–1763, 2004. View at Google Scholar · View at Scopus
  3. T. Kimura and M. Dombo, “Sparassis crispa,” in Biological Activities and Functions of Mushrooms, H. Kawagishi, Ed., pp. 167–178, CMC Press, Tokyo, Japan, 2005. View at Google Scholar
  4. H. J. Shin, D. S. Oh, H. D. Lee, H. B. Kang, C. W. Lee, and W. S. Cha, “Analysis of mineral, amino acid and vitamin contents of fruiting body of Sparassis crispa,” in Journal of Life Sciences, vol. 17, pp. 1290–1293, 2007. View at Google Scholar
  5. M. Dombo, K. Matumura, K. Yuki, and T. Kimura, “Ceramides from Sparassis crispa,” Japanese Kokai Tokkyo Koho, P2005-206576A (August, 2005).
  6. Q. Wang, J. Li, Y. Wang, X. Zhang, and K. Li, “Comparison of aromatic components from Sparassis crispa extracted by Static Headspace and Headspace-SPME,” Shipin Gongye Keji, vol. 32, no. 11, pp. 174–176, 2011. View at Google Scholar
  7. N. Ohno, N. N. Miura, M. Nakajima, and T. Yadomae, “Antitumor 1,3-β-glucan from cultured fruit body of Sparassis crispa,” Biological and Pharmaceutical Bulletin, vol. 23, no. 7, pp. 866–872, 2000. View at Google Scholar · View at Scopus
  8. K. Yamamoto, T. Kimura, A. Sugitachi, and N. Matsuura, “Anti-angiogenic and anti-metastatic effects of β-1,3-D-glucan purified from hanabiratake, Sparassis crispa,” Biological and Pharmaceutical Bulletin, vol. 32, no. 2, pp. 259–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Tada, T. Harada, N. Nagi-Miura et al., “NMR characterization of the structure of a β-(1→3)-D-glucan isolate from cultured fruit bodies of Sparassis crispa,” Carbohydrate Research, vol. 342, no. 17, pp. 2611–2618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Harada, N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno, “Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice,” Biological and Pharmaceutical Bulletin, vol. 25, no. 7, pp. 931–939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Ohno, T. Harada, S. Masuzawa et al., “Antitumor activity and hematopoietic response of beta-glucan extracted from an edible and medicinal mushroom Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae),” International Journal of Medicinal Mushrooms, vol. 4, pp. 13–26, 2002. View at Google Scholar
  12. T. Harada, S. Masuda, M. Arii et al., “Soy isoflavone aglycone modulates A hematopoietic response in combination with soluble β-glucan: SCG,” Biological and Pharmaceutical Bulletin, vol. 28, no. 12, pp. 2342–2345, 2005. View at Google Scholar · View at Scopus
  13. S. Nameda, T. Harada, N. N. Miura et al., “Enhanced cytokine synthesis of leukocytes by a β-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa,” Immunopharmacology and Immunotoxicology, vol. 25, no. 3, pp. 321–335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Harada, N. N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno, “IFN-γ induction by SCG, 1,3-β-D-glucan from Sparassis crispa, in DBA/2 mice in vitro,” Journal of Interferon and Cytokine Research, vol. 22, no. 12, pp. 1227–1239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Harada, N. N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno, “Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) regulates cytokine induction by 1,3-β-D-glucan SCG in DBA/2 mice in vitro,” Journal of Interferon and Cytokine Research, vol. 24, no. 8, pp. 478–489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Harada, N. N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno, “Antibody to soluble 1,3/1,6-β-D-glucan, SCG in sera of naive DBA/2 mice,” Biological and Pharmaceutical Bulletin, vol. 26, no. 8, pp. 1225–1228, 2003. View at Google Scholar · View at Scopus
  17. R. Tada, M. Yoshikawa, T. Kuge et al., “Granulocyte macrophage colony-stimulating factor is required for cytokine induction by a highly 6-branched 1,3-β-D-glucan from Aureobasidium pullulans in mouse-derived splenocytes,” Immunopharmacology and Immunotoxicology, vol. 33, no. 2, pp. 302–308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Harada and N. Ohno, “Contribution of dectin-1 and granulocyte macrophage-colony stimulating factor (GM-CSF) to immunomodulating actions of β-glucan,” International Immunopharmacology, vol. 8, no. 4, pp. 556–566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Sato, H. Sano, D. Iwaki et al., “Direct binding of toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A,” The Journal of Immunology, vol. 171, no. 1, pp. 417–425, 2003. View at Google Scholar · View at Scopus
  20. B. P. Thornton, V. Vĕtvicka, M. Pitman, R. C. Goldman, and G. D. Ross, “Analysis of the sugar specificity and molecular location of the beta-glucan binding lectin site of complement receptor type 3 (CD11b/CD18),” The Journal of Immunology, vol. 156, pp. 1235–1246, 1996. View at Google Scholar
  21. P. J. Rice, J. L. Kelley, G. Kogan et al., “Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans,” Journal of Leukocyte Biology, vol. 72, no. 1, pp. 140–146, 2002. View at Google Scholar · View at Scopus
  22. J. W. Zimmerman, J. Lindermuth, P. A. Fish, G. P. Palace, T. T. Stevenson, and D. E. DeMong, “A novel carbohydrate-glycosphingolipid interaction between a β-(1–3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes,” The Journal of Biological Chemistry, vol. 273, no. 34, pp. 22014–22020, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. G. D. Brown, P. R. Taylor, D. M. Reid et al., “Dectin-1 is a major β-glucan receptor on macrophages,” Journal of Experimental Medicine, vol. 196, no. 3, pp. 407–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. D. M. Reid, N. A. Gow, and G. D. Brown, “Pattern recognition: recent insights from Dectin-1,” Current Opinion in Immunology, vol. 21, no. 1, pp. 30–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Harada, N. N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno, “Highly expressed dectin-1 on bone marrow-derived dendritic cells regulates the sensitivity to β-glucan in DBA/2 mice,” Journal of Interferon and Cytokine Research, vol. 28, no. 8, pp. 477–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Harada, H. Kawaminami, N. N. Miura et al., “Mechanism of enhanced hematopoietic response by soluble β-glucan SCG in cyclophosphamide-treated mice,” Microbiology and Immunology, vol. 50, no. 9, pp. 687–700, 2006. View at Google Scholar · View at Scopus
  27. A. Shibata, T. H. Hida, K. Ishibashi, N. N. Miura, Y. Adachi, and N. Ohno, “Disruption of actin cytoskeleton enhanced cytokine synthesis of splenocytes stimulated with beta-glucan from the cauliflower medicinal mushroom, Sparassis crispa Wulf.:Fr. (higher Basidiomycetes) in vitro,” International Journal of Medicinal Mushrooms, vol. 14, no. 3, pp. 257–269, 2012. View at Google Scholar
  28. H. S. Kim, J. Y. Kim, H. S. Ryu et al., “Induction of dendritic cell maturation by β-glucan isolated from Sparassis crispa,” International Immunopharmacology, vol. 10, no. 10, pp. 1284–1294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Siepmann, “Wachstumshemmung von Stammfaulepilzen und von Gremmeniella abietina durch Bacillus subtilis,” European Journal of Forest Pathology, vol. 17, pp. 59–64, 1987. View at Google Scholar
  30. S. Woodward, H. Y. Sultan, D. K. Barrett, and R. B. Pearce, “Two new antifungal metabolites produced by Sparassis crispa in culture and in decayed trees,” Journal of General Microbiology, vol. 139, no. 1, pp. 153–159, 1993. View at Google Scholar · View at Scopus
  31. H. Kawagishi, K. Hayashi, S. Tokuyama, N. Hashimoto, T. Kimura, and M. Dombo, “Novel bioactive compound from the Sparassis crispa mushroom,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 7, pp. 1804–1806, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Kodani, K. Hayashi, S. Tokuyama et al., “Occurrence and identification of chalcones from the culinary-medicinal cauliflower mushroom Sparassis crispa (Wulf.) Fr. (Aphyllophoromycetideae),” International Journal of Medicinal Mushrooms, vol. 10, no. 4, pp. 331–336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Kodani, K. Hayashi, M. Hashimoto, T. Kimura, M. Dombo, and H. Kawagishi, “New sesquiterpenoid from the mushroom Sparassis crispa,” Bioscience, Biotechnology and Biochemistry, vol. 73, no. 1, pp. 228–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Yoshikawa, N. Kokudo, T. Hashimoto, K. Yamamoto, T. Inose, and T. Kimura, “Novel phthalide compounds from Sparassis crispa (Hanabiratake), Hanabiratakelide A-C, exhibiting anti-cancer related activity,” Biological and Pharmaceutical Bulletin, vol. 33, no. 8, pp. 1355–1359, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Wang, H. X. Wang, and T. B. Ng, “A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa,” Peptides, vol. 28, no. 3, pp. 560–565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Yoshitomi, E. Iwaoka, M. Kubo, M. Shibata, and M. Gao, “Beneficial effect of Sparassis crispa on stroke through activation of Akt/eNOS pathway in brain of SHRSP,” Journal of Natural Medicines, vol. 65, no. 1, pp. 135–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Y. Lee, Y. G. Lee, S. E. Byeon et al., “Mitogen activated protein kinases are prime signalling enzymes in nitric oxide production induced by soluble β-glucan from Sparassis crispa,” Archives of Pharmacal Research, vol. 33, no. 11, pp. 1753–1760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Yamamoto and T. Kimura, “Orally and topically administered Sparassis crispa (Hanabiratake) improves healing of skin wounds in mice with streptozotocin-induced diabetes,” Bioscience, Biotechnology, and Biochemistry. In press.
  39. K. Yamamoto and T. Kimura, “Dietary Sparassis crispa (Hanabiratake) ameliorates plasma levels of adiponectin and glucose in type 2 diabetic mice,” Journal of Health Science, vol. 56, no. 5, pp. 541–546, 2010. View at Google Scholar · View at Scopus
  40. S. Wu, T. F. Lu, S. Wu, and W. J. Guan, “Research progress in G protein-coupled receptor 40,” Yi Chuan, vol. 35, no. 4, pp. 27–34, 2013. View at Google Scholar
  41. K. Yoshikawa, T. Hashimoto, A. Hirasawa et al., “Unsaturated fatty acids derived from Sparassis crispa fruiting body and/or mycelium for inhibiting diabetes mellitus,” Japanese Kokai Tokkyo Koho, P2010-59106A (March, 2010).
  42. A. H. Kwon, Z. Qiu, M. Hashimoto, K. Yamamoto, and T. Kimura, “Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin-induced diabetic rats,” American Journal of Surgery, vol. 197, no. 4, pp. 503–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Yamamoto, Y. Nishikawa, T. Kimura, M. Dombo, N. Matsuura, and A. Sugitachi, “Antitumor activities of low molecular weight fraction derived from the cultured fruit body of Sparassis crispa in tumor-bearing mice,” Nippon Shokuhin Kagaku Kogaku Kaishi, vol. 54, no. 9, pp. 419–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Yao, K. Yamamoto, T. Kimura, and M. Dombo, “Effects of Hanabiratake (Sparassis crispa) on allergic rhinitis in OVA-sensitized mice,” Food Science and Technology Research, vol. 14, no. 6, pp. 589–594, 2008. View at Google Scholar
  45. H. H. Kim, S. Lee, T. S. Singh, J. K. Choi, T. Y. Shin, and S. H. Kim, “Sparassis crispa suppresses mast cell-mediated allergic inflammation: role of calcium, mitogen-activated protein kinase and nuclear factor-κB,” International Journal of Molecular Medicine, vol. 30, no. 2, pp. 344–350, 2012. View at Google Scholar
  46. T. Kimura, “The physiological function of beta-glucan in Sparassis crispa,” Food Processing and Ingredients, vol. 44, no. 11, pp. 14–15, 2009. View at Google Scholar
  47. N. Ohno, S. Nameda, T. Harada et al., “Immunomodulating activity of a beta-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae) and application to cancer patients,” International Journal of Medicinal Mushrooms, vol. 5, pp. 359–368, 2003. View at Google Scholar
  48. J. Chen, W. Gu, and K. Zhao, “The role of PI3K/Akt pathway in β-glucan-induced dendritic cell maturation,” International Immunopharmacology, vol. 11, no. 4, p. 529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. H. G. Park, Y. Y. Shim, S. O. Choi, and W. M. Park, “New method development for nanoparticle extraction of water-soluble β-(1→3)-D-glucan from edible mushrooms, Sparassis crispa and Phellinus linteus,” Journal of Agricultural and Food Chemistry, vol. 57, no. 6, pp. 2147–2154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Uchiyama, “Sparassis crispa extractions, resveratrol, and collagen peptide as antiaging agents and food supplements,” Japanese Tokkyo Koho, P5016535 (June, 2012).